Skip to main content

Adaptive Biotechnologies Corp

ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001478320

In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 14 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.

13F holders, Q1 2023

Institutional positions in Adaptive Biotechnologies Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
227
+5 vs. Q4 2022
Shares held
133.8M
+980.1K (+0.7%) vs. Q4 2022
Total value
$1.18B
+$165.3M (+16.3%) vs. Q4 2022
New holders
26
85 more added
Sold out
21
63 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 227 institutions
Q1 2021: 249 institutionsQ2 2021: 231 institutionsQ3 2021: 220 institutionsQ4 2021: 214 institutionsQ1 2022: 221 institutionsQ2 2022: 210 institutionsQ3 2022: 226 institutionsQ4 2022: 223 institutionsQ1 2023: 227 institutionsQ2 2023: 210 institutionsQ3 2023: 191 institutionsQ4 2023: 200 institutionsQ1 2024: 190 institutionsQ2 2024: 177 institutionsQ3 2024: 187 institutionsQ4 2024: 207 institutionsQ1 2025: 225 institutionsQ2 2025: 242 institutionsQ3 2025: 271 institutionsQ4 2025: 284 institutionsQ1 2026: 299 institutionsQ2 2026: 301 institutions
Value heldQ1 2023: $1.18B
Q1 2021: $4.58BQ2 2021: $4.80BQ3 2021: $4.00BQ4 2021: $3.46BQ1 2022: $1.74BQ2 2022: $1.08BQ3 2022: $931.2MQ4 2022: $1.01BQ1 2023: $1.18BQ2 2023: $920.9MQ3 2023: $769.4MQ4 2023: $704.0MQ1 2024: $457.4MQ2 2024: $538.6MQ3 2024: $732.5MQ4 2024: $858.6MQ1 2025: $1.14BQ2 2025: $1.73BQ3 2025: $2.18BQ4 2025: $2.44BQ1 2026: $2.11BQ2 2026: $3.34B
Institutions holding ADPT and their total value by quarter
QuarterHoldersValue
Q2 2026301$3.34B
Q1 2026299$2.11B
Q4 2025284$2.44B
Q3 2025271$2.18B
Q2 2025242$1.73B
Q1 2025225$1.14B
Q4 2024207$858.6M
Q3 2024187$732.5M
Q2 2024177$538.6M
Q1 2024190$457.4M
Q4 2023200$704.0M
Q3 2023191$769.4M
Q2 2023210$920.9M
Q1 2023227$1.18B
Q4 2022223$1.01B
Q3 2022226$931.2M
Q2 2022210$1.08B
Q1 2022221$1.74B
Q4 2021214$3.46B
Q3 2021220$4.00B
Q2 2021231$4.80B
Q1 2021249$4.58B

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Adaptive Biotechnologies Corp; share changes are against Q4 2022.

Institutions holding ADPT in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Norges Bank805,972$7.12M0.00%−274,249−25.4%Reduced
Charles Schwab Investment Management Inc823,319$7.27M0.00%−1,080−0.1%Reduced
Pier Capital, LLC823,986$7.28M1.10%−188,415−18.6%Reduced
Northern Trust Corp1,032,706$9.12M0.00%+37,297+3.7%Added
T. Rowe Price Investment Management, Inc.1,080,528$9.54M0.01%+412,326+61.7%Added
Gilder Gagnon Howe & Co LLC1,169,520$10.3M0.17%+1,169,520New
Federated Hermes, Inc.1,176,056$10.4M0.03%−231,130−16.4%Reduced
Eagle Health Investments LP1,214,860$10.7M2.09%+607,000+99.9%Added
Nuveen Asset Management, LLC1,226,140$10.8M0.00%+419,347+52.0%Added
Principal Financial Group Inc1,247,131$11.0M0.01%−9,780−0.8%Reduced
Goldman Sachs Group Inc1,499,737$13.2M0.00%+209,162+16.2%Added
Dimensional Fund Advisors LP1,648,361$14.6M0.00%+628,622+61.6%Added
Price T Rowe Associates Inc1,758,949$15.5M0.00%−79,517−4.3%Reduced
Pictet Asset Management SA1,884,240$16.6M0.02%+1,251,512+197.8%Added
Aristotle Atlantic Partners, LLC1,907,089$16.8M0.87%+26,522+1.4%Added
Geode Capital Management, LLC2,215,980$19.6M0.00%+70,337+3.3%Added
Massachusetts Financial Services Co2,279,210$20.1M0.01%+924,777+68.3%Added
State Street Corp2,568,042$22.7M0.00%+66,589+2.7%Added
Blue Water Life Science Advisors, LLC3,030,434$26.8M17.69%00.0%Unchanged
Nikko Asset Management Americas, Inc.5,322,536$44.7M0.51%−29,779−0.6%Reduced
Sumitomo Mitsui Trust Holdings, Inc.5,322,536$47.0M0.04%−29,779−0.6%Reduced
ARK Investment Management LLCSuperinvestorARK Invest9,205,125$81.3M0.56%+3,8800.0%Added
Matrix Capital Management Company, LP11,572,590$102.2M1.39%00.0%Unchanged
BlackRock Inc.11,768,441$103.9M0.00%−605,756−4.9%Reduced
Vanguard Group Inc11,977,414$105.8M0.00%+183,246+1.6%Added
Viking Global Investors LPSuperinvestorViking Global Investors29,993,708$264.8M1.24%00.0%Unchanged
IFP Advisors, Inc32––+32New
Bellevue Group AG0$00.00%−2,960,131−100.0%Sold out
Marshall Wace, LLP0$00.00%−370,471−100.0%Sold out
Frontier Capital Management Co LLC0$00.00%−184,433−100.0%Sold out
Trexquant Investment LP0$00.00%−123,841−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−111,982−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−102,841−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−89,119−100.0%Sold out
Squarepoint Ops LLC0$00.00%−50,889−100.0%Sold out
Clarius Group, LLC0$00.00%−23,824−100.0%Sold out
Walleye Capital LLC0$00.00%−22,168−100.0%Sold out
Alpine Global Management, LLC0$00.00%−16,008−100.0%Sold out
DuPont Capital Management Corp0$00.00%−14,650−100.0%Sold out
Meeder Asset Management Inc0$00.00%−5,632−100.0%Sold out
State of Wyoming0$00.00%−3,468−100.0%Sold out
Point72 Middle East FZE0$00.00%−3,455−100.0%Sold out
Steward Financial Group LLC0$00.00%−1,600−100.0%Sold out
Belvedere Trading LLC0$00.00%−986−100.0%Sold out
Truvestments Capital LLC0$00.00%−229−100.0%Sold out
Accurate Wealth Management, LLC0$00.00%−92−100.0%Sold out
Comerica Securities,inc.0$00.00%−67−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−55−100.0%Sold out
Trustcore Financial Services, LLC––––Not filed